Atresmedia Corporación de Medios de Comunicación S A : Shareholders' General Meeting Agreements held on 29th April 2020

TO THE COMISIÓN NACIONAL DEL MERCADO DE VALORES

In accordance with the provisions of Article 227 of the Ley del Mercado de Valores, Atresmedia Corporación de Medios de Comunicación, S.A. (Atresmedia) hereby notifies the following

RELEVANT INFORMATION

The Ordinary Shareholders´General Meeting of Atresmedia Corporación, held yesterday 29th April 2020, at first call, has adopted the following

AGREEMENTS

Agreements concerning item 1 of the agenda

Annual accounts, management reports, allocation of the profit obtained and corporate management in connection with year 2019.

1. Scrutiny and approval of the annual accounts and management report of Atresmedia Corporación de Medios de Comunicación, S.A., both on an individual and on a consolidated basis, for the year ended on 31st December 2019.
   Approval, according to the terms reflected in the legal documentation, of the annual accounts and management report of Atresmedia Corporación de Medios de Comunicación, S.A. for year 2019, both on an individual and on a consolidated basis, as they have been formulated by the Board of Directors.
2. Approval of the Statement of non-financial information as at 31st December 2019, which forms part of the consolidated management report.
   Approval of the Statement of non-financial information as at 31st December 2019, which forms part of the consolidated management report.
3. Proposal not voted
4. Approval of the corporate management of the Company by the Board of Directors in 2019.
   Approval of the corporate management of the Company by the Board of Directors in 2019.

Agreement concerning item 2 of the agenda

Re-election of the company KPMG AUDITORES S.L. as the external auditors of Atresmedia Corporación de Medios de Comunicación, S.A. and its consolidated group of companies for 2020.

Re-election of the company KPMG AUDITORES S.L. as the external auditors in charge of the scrutiny of the annual accounts of Atresmedia Corporación de Medios de Comunicación, S.A. and its consolidated group of companies for 2020.

Agreement concerning item 3 of the agenda

Re-election of director.

Re-election of Ms. Mónica Ribé Salat as independent director of the Company, for a term of four years, following the proposal of the Appointments and Remunerations Committee, based on a favourable report issued by the Board of Directors.

Avda. Isla Graciosa, 13. 28703 San Sebastián de los Reyes, Madrid. Tel. [phone]. www.atresmediacorporacion.com

Agreement concerning item 4 of the agenda

Authorisation to buy back treasury shares, either directly or through Group Companies.

Authorise the Company so that, either directly or through the intermediary of any of its affiliate companies, so that it may acquire fully paid-up shares of Atresmedia Corporación de Medios de Comunicación, S.A., by any legal means, including their purchase against the profit for the year and/or unrestricted reserves, and subsequently dispose of such shares, in accordance with the provisions of articles 146, 509 and related articles of the Corporations Act, delegating to the Board of Directors any powers deemed necessary for the enforcement of the resolutions adopted by the General Meeting in this respect.

The acquisition of treasury shares will be subject to the following terms and conditions:

• The nominal value of the acquired shares, which wi be added to those already owned by Atresmedia Corporación de Medios de Comunicación, S.A. and its subsidiaries, should not exceed the maximum threshold set out from time to time by the legislation in force.
• The acquisition, including shares previously acquired by the Company and held by it, and shares acquired and held by any person acting in his own name but on the
  Company's behalf, may not have the effect of reducing the net assets below an amount equivalent to the capital stock plus those reserves which may not be distributed under the law or the corporate byelaws. To that effect, net assets will be understood as the amount defined as such in accordance with the criteria used in the preparation of the annual accounts, less the amount of profit directly allocated to that sum, plus the amount of the uncalled share capital and the par value and issue premiums of the subscribed capital stock included in the liabilities side of the balance sheet.
• The shares so acquired must be fully paid-up.
• The acquisition price will neither be less than the nominal value of the shares nor higher by twenty percent (20%) than their listing value, and the purchase transactions must abide by the standards and practices of the stock exchange markets.
• The obligation laid down in article 148 c) of the Corporations Act, consisting of the creation of a restricted reserve in the liabilities side of the balance sheet of the Company which is equivalent to the amount of the shares of the Parent Company recorded in the assets side of the balance sheet, without depleting the capital or restricted legal or statutory reserves, must be complied with. This reserve should be maintained until such time as those shares are disposed of.
• The Management Report to be issued in due course by the Board of Directors should at

least include the information referred to in article 148 d) of the Corporations Act.

It is expressly authorised that the subsidiaries of the Company may purchase or otherwise acquire in return for payment the shares of the Company, subject to the same terms, conditions and restrictions as this resolution. Similarly, it is expressly authorized that the shares acquired by the Company or its subsidiaries by virtue of this authorization can be allocated, wholly or partially, to their delivery to beneficiaries of future remuneration schemes or to the exercise of any option rights enjoyed by the staff, the employees or the directors of the Company. The aim of this authorization is expressly stated for the purposes set out in article 146.1 a) of the Corporations Act.

The Board of Directors is authorized, to the broadest extent, to use the authorization that is the subject matter of this resolution and to fully execute and develop it. Furthermore, the Board of Directors is authorized to delegate such powers in favour of the Executive Committee, the Chief Executive Officer or any other person expressly empowered by the Board in this respect and to the extent considered appropriate; where appropriate, the Internal Conduct Regulations concerning stock market-related issues in force at the Company shall be applied.

2

This authorization will have an effective term of five (5) years, from the date of this General Meeting and will have no effect, as to the part not yet executed, the authorization granted to the Board of Directors by the Ordinary General Meeting of Shareholders held on 22nd April 2015.

Agreement concerning item 5 of the agenda

Delegation of powers in favour of the Board of Directors, so that this latter may issue, on behalf of the Company and in one or more issues, debentures, bonds and other fixed-income securities or other similar debt instruments, either non- convertible or exchangeable for outstanding shares or other pre-existing securities of other companies, as well as promissory notes and preferred shares, with express permission to delegate said authority and for a maximum term of five (5) years. Delegation of powers.

Delegation of powers to the Board of Directors of the Company, with express substitution powers, in accordance with the provisions contained in article 401 and the following ones of the Corporations Act and article 319 of the Commercial Registry Regulations, so that the Board may issue fixed income securities or other analogous debt instruments, subject to the following terms and conditions:

1. Issued securities
   The marketable securities concerned by this delegation of powers may consist of any type of debentures, bonds and other fixed income securities or other analogous debt instruments permitted by the law, either of the straight type or exchangeable for outstanding shares or other pre-existing securities of other companies. Similarly, this authorisation may also be used to issue preferred shares and other similar securities, as well as promissory notes, under this name or any other one (the "Securities"). The delegation of powers includes the authorisation to establish and/or renew tap issue or open issue schemes regarding the issue of securities, bonds and other analogous fixed income securities, as well as promissory notes, under this name or any other one.
2. Effective term of the delegation of powers
   The securities may be issued in one or several issues, at any time within a maximum term of five (5) years starting on the date of adoption of this resolution
3. Maximum amount covered by the delegation of powers
   The maximum total amount of the issue or issues of securities made under this delegation of powers may not exceed an aggregate nominal amount of EURO THREE HUNDRED MILLION (€ 300,000,000) or its equivalent in another currency.
   As far as the limits of the delegation are concerned, the aforementioned amount represents the maximum global limit that may reach at all times the sum of the nominal outstanding amount of the promissory notes or analogous securities issued plus the nominal issued amount of the remaining securities issued under this authorisation granted to the Board of Directors.
4. Scope of the delegation
   The Board of Directors shall determine the terms and conditions applicable to each issue, including, without limitation:
5. 1. The amount (always within the above-mentioned global quantitative thresholds).
   2. The place of issue -either in Spain or abroad- and the applicable currency including, in case of a foreign currency, its euro equivalent.
   3. The type and designation of the securities, either bonds or debentures, or even subordinated debentures, promissory notes or any other analogous fixed income securities, or any other legally admitted securities, that may be fully or partially exchangeable (necessarily or voluntarily, and in this latter case, at the option of the holder and/or the issuer) for outstanding shares or other pre-existing

3

securities of other companies, or if they should incorporate a call option.

1. 1. The issue date or dates.
   2. The number of securities and their nominal value.
   3. The interest rates, the dates and the coupon payment methods, or any other indexes or parameters.
   4. The nature of the issue, either perpetual or redeemable and, in this latter case, the term and the modalities of redemption and the maturity date or dates.
   5. The applicable antidilution schemes and clauses, if any.
   6. The priority scheme or the subordination clauses, if any.
   7. Repayment rate, premiums and prizes.
   8. The guarantees of the issue, if applicable.
   9. Method of representation of the relevant securities, either by means of certificates, book entries or through any other method legally admitted.
   10. The securities underwriting method.
   11. The domestic or foreign legislation applicable.
   12. If appropriate, to apply for admission to trading in secondary markets, either official or not, organised or over-the counter, domestic or foreign, of the securities to be issued by virtue of this delegation of powers, subject to the requirements called for the applicable regulations, on a case-by-case basis and, in general terms, subject to any other terms and conditions of the issue.
   13. If appropriate, to appoint the Commissioner and approve the basic rules governing the legal relationships between the Company and the syndicate of holders of the securities to be issued.
   14. In the case of programmes concerning promissory notes, the total maximum amount of the program or programmes, the maximum and minimum nominal amounts of the promissory notes to be issued, the procedure or system chosen for the issue and allocation of such promissory notes and, in general, any other aspect or condition of the issuers or programmes, including their subsequent amendment.
   15. The execution of any formalities that might be required, in accordance with the regulations in force at the relevant market, for the implementation of the specific issues to be agreed under this Delegation of powers.
   16. Furthermore, the delegation of powers in favour of the Board of Directors will also include, when deemed appropriate by the Board, the power to amend the conditions of application to the issue of securities, subject to the granting of the relevant permits required.
2. Admission to trading
   The Board of Directors is authorised to apply for the admission to trading of the securities that are the subject matter of this delegation of powers, in secondary markets, either official or not, organised or over the counter, domestic or foreign, and the Authorisation expressly includes substitution powers in favour of the Chief Executive Officer, the Secretary and the Deputy Secretary, so that they may carry out the formalities required before the bodies with jurisdiction of the Different domestic or foreign Stock Markets, in the context of the admission of the securities to trading.
   The Board is also authorised, if appropriate, to apply for the suspension of the trading of the securities to be issued by the Company under this resolution. In any case, such suspension will be carried out in accordance with the legislation in force.
3. Delegation of Powers
   Without prejudice to the specific delegations of powers contained in the previous paragraphs (that should be understood as granted with express substitution powers in favour of the bodies and individuals specified herein), the Board of Directors will be

4

authorised, to the broadest extent required by law, and with express powers of delegation to the Chief Executive Officer, the Secretary and the Deputy Secretary of the Board, so that any of them, joint and severally, may indistinctly apply for any authorisations and adopt any resolutions deemed necessary or convenient for the compliance with the legislation in force, the implementation and the effectiveness of this resolution, including the performing of any formalities and the underwriting of any public or private deeds and prospectuses that might be required in accordance with the delegation of powers that is the subject matter of this resolution.

The approval of this resolution renders null and void, as to the part not yet executed, the authorisation granted to the Board of Directors which was included in the fourth item of the Agenda of the General Meeting of Shareholders of the Company held on 22nd April 2015.

Agreement concerning item 6 of the agenda

Delegation of powers in favour of the Board of Directors, so that this latter may issue, on behalf of the Company and in one or more issues, and for a maximum term of five (5) years, debentures and/or bonds convertible into new shares of the Company and/or exchangeable for Company shares, as well as warrants on new shares or on outstanding shares of the Company, with express authorisation, in case of an issue of convertible debentures and/or bonds or warrants on new shares, to exclude the preferential subscription right of shareholders and to increase the capital stock to the extent necessary to meet the requirements of the conversion. Establishment of criteria for the determination of the conversion rules and options. Delegation of powers.

Delegation of powers to the Board of Directors, with express substitution powers, in accordance with the provisions of articles 297.1.b), 401 and the following ones, 417 and 511 of the Corporations Act and Article 319 of the Commercial registry Regulations, so that the Board may issue marketable securities, subject to the following terms and conditions:

1. Issued securities
   The marketable securities concerned by this delegation of powers may consist of debentures and/or bonds convertible into new shares of the common stock of the Company and/or exchangeable for outstanding shares of the Company, as well as warrants on newly issued shares or outstanding shares of the Company (the
   "Securities").
2. Effective term of the delegation of powers
   The securities may be issued in one or several issues, at any time within a maximum term of five (5) years starting on the date of adoption of this resolution.
3. Maximum amount covered by the delegation of powers
   The maximum total amount of the issue or issues of securities made under this delegation of powers may not exceed an aggregate nominal amount of EURO THREE HUNDRED MILLION (€ 300,000,000) or its equivalent in another currency.
4. Scope of the delegation
   The Board of Directors shall determine the terms and conditions applicable to each issue, including, without limitation:
5. 1. The amount (always within the above-mentioned global quantitative thresholds).
   2. The place of issue -either in Spain or abroad- and the applicable currency including, in case of a foreign currency, its euro equivalent.
   3. The type and designation of the securities, either bonds or debentures, or even subordinated debentures or any other legally admitted securities.
   4. The issue date or dates.
   5. The number of securities and their nominal value, which may not be lower than

5

the par value of the shares.

1. 1. The interest rates, the dates and the coupon payment methods, including the possibility of a remuneration based on the evolution of the price of the Company's shares or on any other indexes or parameters.
   2. The nature of the issue, either perpetual or redeemable and, in this latter case, the term and the modalities of redemption and the maturity date or dates.
   3. The convertible and/or exchangeable nature of the issue, as well as the possibility of converting, exchanging or redeeming the issue, either wholly or partially, at any time and in cash.
   4. The applicable antidilution mechanisms and clauses, if any.
   5. The priority scheme and the subordination clauses, if appropriate.
   6. The Repayment rate, premiums and prizes.
   7. The guarantees of the issue, if applicable.
   8. Method of representation of the relevant securities, either by means of certificates, book entries or through any other method legally admitted.
   9. The conditions of application to exercise -or to be excluded from the exercise of- the preferential subscription right of shareholders, and in general, the applicable scheme for the underwriting and payment of the securities.
   10. The possibility of incomplete subscription of the issue.
   11. The applicable legislation, either domestic or foreign.
   12. The execution of any formalities that might be required, in accordance with the regulations in force at the relevant market, for the implementation of the specific issues to be agreed under this Delegation of powers.
   13. If appropriate, to apply for admission to trading in secondary markets, either official or not, organised or over-the counter, domestic or foreign, of the securities to be issued by virtue of this delegation of powers, subject to the requirements called for the applicable regulations, on a case-by-case basis and, in general terms, subject to any other terms and conditions of the issue.
   14. If appropriate, to appoint the Commissioner and approve the basic rules governing the legal relationships between the Company and the syndicate of holders of the securities to be issued.
   15. Furthermore, the delegation of powers in favour of the Board of Directors will also include, when deemed appropriate by the Board, the power to amend, subject to the granting of the permits required, the conditions of application to the issue of securities.
2. Exclusion of the pre-emptive subscription right
   The Board of Directors is expressly authorised, pursuant to the provisions of articles 417 and 511 of the Corporations Act, to exclude, wholly or partially, the exercise of the pre-emptive subscription right of the shareholders, in connection with issues of convertible bonds and securities and warrants on newly issued shares, when deemed appropriate or convenient for the sake of the corporate interest. In any case, if the Board of Directors decides to exclude the pre-emptive subscription right, the Board will prepare the mandatory report of the directors of the Company, including, as specified in the Corporations Act, the relevant report issued by the Accounts Auditor. These reports will be made available for the shareholders and shall be notified to the first General Meeting to be held after the relevant resolution regarding the issue of securities.
3. Bases and methods for conversion and/or exchange
   In the event of any issue of convertible and/or exchangeable bonds and/or debentures, and for the purposes of establishing the bases and methods for the conversion and/or exchange, these shall be determined by the Board of Directors for each individual issue launched under the delegation granted, in accordance with the following criteria:

6

1. Any securities to be issued under this resolution may be converted into new shares of the Company and/or exchangeable for shares of the Company, according to a specific or determinable conversion and/or exchange rate, either fixed or variable, and the Board of Directors will be authorised to determine whether they are convertible and/or exchangeable or both, and to determine whether they are necessarily or voluntarily convertible and/or exchangeable on the basis of any objective criterion, and in case that they can be voluntarily convertible and/or exchangeable, whether this should be done at the option of the holder or the issuer, subject to the periodicity and within the time limits laid down in the resolution on their issue, that shall not exceed ten (10) years from the date of issue, or whether they are perpetual, if so permitted by the applicable legislation, including the possibility of a full or partial redemption, at any time and in cash, at the option of the holder or of the issuer.
2. In case of a fixed rate of conversion and/or exchange for Company shares, the convertible and/or exchangeable bonds and/or debentures will be valued at their par value, and the shares will be valued at the fixed exchange rate to be determined through a resolution of the Board of Directors, or at the exchange rate to be determined on the date or dates to be indicated in the resolution of the Board, and on the basis of the stock market price of the Company shares on the reference date(s) or period(s) indicated in the resolution. Furthermore, a premium or, if appropriate, a discount on the share price may also be established.
3. The debentures or bonds may also be issued at a variable rate of conversion and/or exchange. In this case, the price of the shares, for the purposes of the conversion and/or exchange, will be the arithmetic mean of the closing prices, the weighted average price or any other reference to the stock market price of the Company Shares on the Continuous Trading market, over a period to be defined by the Board of Directors, with or without premium or, if appropriate, a discount on such share price. Notwithstanding the above, and subject to the conditions to be established by the Board of Directors, a minimum and/or a maximum reference price may be established in connection with the shares, for the purpose of their conversion and/or exchange.
4. In case of exchange for shares of another Company (belonging or not to the Group of Companies) the rules established in paragraphs a) and b) above will be applied, mutatis mutandis and where appropriate, although they will be referred to the stock market price of the shares of such company at the relevant market.
5. For the purposes of the rate of conversion of debentures into shares, the share price may never be lower than the par value. In accordance with the provisions contained in article 415 of the Corporations Act, debentures may not be converted into shares when the par value of the former is lower than that of the latter ones. Convertible debentures may neither be issued for an amount below their par value.
6. In case of a convertible and exchangeable issue, the Board of Directors may decide that the Company will be entitled, at any time, to choose between the conversion into new shares or the exchange for outstanding shares, and the nature of the shares to be delivered shall be specified at the time of the conversion or exchange, although the Company may also deliver a combination of newly issued shares and already existing shares or an equivalent cash amount. In any case, an equal treatment shall be ensured for all those holders of fixed income securities who convert and/or exchange their securities on a given date.
7. In case of conversion and/or exchange, fractions of shares to be delivered, if any, to the holder of the bonds or debentures will be rounded down by default to the nearest whole number, and each holder will receive in cash the eventual difference.

7

1. According to articles 417 and 511 of the Corporations Act, when any issue of convertible bonds or debentures is approved, and the exercise of the pre-emptive subscription right of the shareholders is wholly or partially excluded, under the provisions of the authorisation contained in this resolution, the Board of Directors shall prepare a report where the bases and conversion methods specifically applied to such issue will be developed and specified, on the basis of the aforementioned criteria. This report will also include the relevant audit report referred to in Article 414.2 of the Corporations Act, which will be prepared by an auditor other than the
   Company's auditor, appointed for such purposes by the Commercial Registry.

Furthermore, these reports will be made available for the shareholders and shall be notified to the first General Meeting to be held after the relevant resolution regarding the issue.

Authority is conferred to the Board of Directors, so that it may develop and specify the bases and types of the conversion and/or exchange previously established, and especially, to determine the timing of the conversion and/or exchange, that may be limited to a period established beforehand, the ownership of the conversion and/or exchange right, that may correspond to the Company itself or to the holders of debentures and/or bonds, the method of compensating the debenture holders (either through conversion, exchange, delivery of a cash amount or any combination of the above, or even a compulsory conversion, that will be freely determined by the Board at its convenience, even at the time of the execution) and, in general, any other conditions or particulars deemed necessary or convenient for each specific issue.

1. Bases and methods for the exercise of the warrants
   The rules defined in the previous paragraphs will be of application, mutatis mutandis, when warrants or any other analogous securities are issued, in case that they may directly or indirectly confer the right to underwrite newly issued shares of the company, and the delegation of powers will comprise the broadest powers, within the same scope as in the previous paragraphs, to decide what is deemed more convenient in connection with such class of securities.
2. Rights of the holders of convertible securities
   The holders of those securities to be eventually issued in accordance with the authorisation contained in this resolution will enjoy all those rights conferred by the regulations in force in connection with the issue and by the resolution regarding the issue of shares
3. Increase of Capital
   Authorisation is delegated to the Board of Directors to increase the capital stock through the issue of new ordinary shares, in the amount required to meet the requests for conversion of the convertible securities issued according to this resolution. Such authorisation will be subject to the condition that the total number of capital increases agreed by the Board of Directors, including those increases agreed as a result of this delegation of powers and those implemented according to other authorisations granted by the Shareholders' Meeting, does neither exceed fifty per cent of the current capital stock foreseen in article 297.1 b) in fine of the Corporations Act, nor twenty per cent (20%) of such total capital stock figure, in case that the pre-emptive subscription right enjoyed by the shareholders is excluded from the issue of convertible securities.
   This authorisation to increase the capital stock also allows to issue and have outstanding, in one or several times, the necessary number of shares of the capital stock that are required to implement the conversion, and to redraft article 5 of the Corporate Byelaws, concerning the amount of the capital stock of the Company and, if appropriate, to render null and void the relevant tranche of such capital increase which had not been required for the conversion into shares.

8

1. Admission to trading
   Authorisation is delegated to the Board of Directors, with express powers of delegation to the Chief Executive Officer, the Secretary and the Deputy Secretary of the Board, so that they may apply for the admission to trading of the securities that are the subject matter of this delegation of powers, in secondary markets, either official or not, organised or over the counter, domestic or foreign, and to carry out any formalities and actions deemed necessary or convenient before the bodies with jurisdiction of the Different domestic or foreign Stock Markets, in the context of the admission of the securities to trading.
   Furthermore, authorisation is delegated to the Board of Directors so that they may apply for the admission to trading of the new ordinary shares that may be issued to meet the requests for conversion of the securities issued under this resolution in the Madrid, Barcelona, Bilbao and Valencia stock exchange markets, as well as in any other markets wherein the company shares are listed at the time of implementation of this resolution, and their integration within the Spanish Stock exchange Interconnection System (SIBE).
   It is expressly stated that, in case that the exclusion from trading is subsequently applied for, it will be subject to the same formalities, as far as they are applicable, as the application for trading and, in such event, the interests of those shareholders or debenture holders who object or vote against such resolution will be preserved in accordance with the provisions established by the legislation in force. Furthermore, it is expressly stated that the Company will be subject to the stock market regulations currently in force or that might be enacted in future, and especially, those regarding the trading, maintenance and exclusion from trading.
2. Delegation of powers
   Without prejudice to the specific delegations of powers contained in the previous paragraphs (that should be understood as granted with express substitution powers in favour of the bodies and individuals specified herein), the Board of Directors will be authorised, to the broadest extent required by law, and with express powers of delegation to the Chief Executive Officer, the Secretary and the Deputy Secretary of the Board, so that any of them, joint and severally, may indistinctly apply for any authorisations and adopt any resolutions deemed necessary or convenient for the compliance with the legislation in force, the implementation and the effectiveness of this resolution, including the completion of any formalities and the underwriting of any public or private deeds, agency, underwriting, calculation and other agreements that might be required for an issue of this type of securities, as well as those prospectuses that might be required under the delegation of powers that is the subject matter of this resolution.
   The approval of this resolution renders null and void, as to the part not yet executed, the authorisation granted to the Board of Directors which was included in the fourth item of the Agenda of the General Meeting of Shareholders of the Company held on 22nd April 2015.

Proposal concerning item 7 of the agenda

Proposal not voted.

9

Agreement concerning item 8 of the agenda

Delegation of powers to formulate, construe, make good and enforce the resolutions adopted by the General Meeting, and to replace the powers granted to the Board of Directors by the Meeting.

To authorise the Board of Directors of the Company, as broadly as required by law and with express powers of delegation to the Chairman of the Board of Directors, the Chief Executive Officer, The Secretary and the Deputy Secretary of the Board, so that either the Board of Directors or any of them, joint and severally, may indistinctly carry out any actions deemed appropriate in connection with the formulation, construction, amendment and full enforcement of the resolutions adopted by this General Meeting.

Agreement concerning item 9 of the agenda

Advisory vote on the Annual Report on the remunerations received by the Directors 2019.

To vote, on an advisory basis, on the Annual Report on the remunerations received by the Directors of Atresmedia Corporación de Medios de Comunicación, S.A. in 2019.

Proposal concerning item 10 of the agenda

Proposal not voted

The proposals relating to items 1.3, 7 and 10 of the agenda have not been submitted to the vote by the General Shareholders' Meeting. The first two items for having previously withdrawn by agreement of the Board of Directors (Information sent to the CNMV nº180 dated April 23rd, 2020), and the last item for having the Board of Directors required the intervention of a Notary in the Meeting.

San Sebastián de los Reyes, Madrid, 30th April 2020

10